Free website hits

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of Zoom meetings, Skype calls, and deadlines has predictably returned. But what can you do ? The world keeps spinning. So why not give it a push? On that note, time for a cup of stimulation, because we also need a push. Our choice today is the lovely coconut. Feel free to join us. Meanwhile, here are some tidbits to get you going. Hope you have a smashing day, and do stay in touch. …

The World Health Organization approved the Covid-19 vaccine from AstraZeneca (AZN) for emergency use, clearing the way for the first shipments of free vaccines in the West’s main effort to inoculate the world’s poorest nations, The Wall Street Journal writes. Many developing countries rely on the WHO’s emergency-use listing to authorize the shots at home, and it also triggers purchase orders that Covax, a WHO-supported initiative, made with vaccine manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Source: STATNEWS.COM

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]